Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
about
The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients.The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients.Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study.
P2860
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@ast
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@en
type
label
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@ast
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@en
prefLabel
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@ast
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@en
P2860
P356
P1476
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
@en
P2093
Holger Schmid
P2860
P304
P356
10.2147/CEOR.S46930
P407
P577
2014-07-03T00:00:00Z